VT Cryoablation System Post-Market Clinical Follow-up

  • Research type

    Research Study

  • Full title

    Adagio Medical VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study Protocol Number CS-190

  • IRAS ID

    326018

  • Contact name

    Neil Srinivasan

  • Contact email

    neil.srinivasan2@nhs.net

  • Sponsor organisation

    Adagio Medical Inc

  • Clinicaltrials.gov Identifier

    NCT06384599

  • Duration of Study in the UK

    1 years, 2 months, 29 days

  • Research summary

    The purpose of this Post-Market Clinical Follow-Up (PMCF) is to collect clinical data for the Adagio Medical vCLAS™ Cryoablation System when used as intended (per Instructions for Use, the Declaration of Conformity and approved labelling). The Adagio Medical vCLAS™ Cryoablation System will be used to treat monomorphic Ventricular Arrhythmias.
    This study is a post-market follow up (after commercialization) to collect real world safety and performance data of the vCLAS Cryoablation system in the approved indication.

  • REC name

    North West - Liverpool Central Research Ethics Committee

  • REC reference

    24/NW/0266

  • Date of REC Opinion

    1 Nov 2024

  • REC opinion

    Further Information Favourable Opinion